Neutralizing human monoclonal antibodies prevent Zika virus infection in macaques

Science Translational Medicine

Volumn 9, Issue 410, 2017, Pages

  Magnani, Diogo M ^a   Rogers, Thomas F ^b   Beutler, Nathan ^b   Ricciardi, Michael J ^a   Bailey, Varian K ^a   Gonzalez Nieto, Lucas ^a   Briney, Bryan ^b   Sok, Devin ^b   Le, Khoa ^b   Strube, Alexander ^a,b   Gutman, Martin J ^a   Pedreno Lopez, Nuria ^a   Grubaugh, Nathan D ^b   Silveira, Cassia G T ^c   Maxwell, Helen S ^a   Domingues, Aline ^a   Martins, Mauricio A ^a   Lee, David E ^d   Okwuazi, Erica E ^d   Jean, Sherrie ^d   Strobert, Elizabeth A ^d   Chahroudi, Ann ^d,e   Silvestri, Guido ^d   Vanderford, Thomas H ^d   Kallas, Esper G ^c   Desrosiers, Ronald C ^a   Bonaldo, Myrna C ^f   Whitehead, Stephen S ^g   Burton, Dennis R ^b,h   Watkins, David I ^a   more..

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d EMORY UNIVERSITY   (United States)

^e EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f INSTITUTO OSWALDO CRUZ   (Brazil)

^g NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^h MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; FC RECEPTOR; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; SMZ ANTIBODY 1; SMZ ANTIBODY 2; SMZ ANTIBODY 5; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; BIOENGINEERING; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IN VITRO STUDY; LIMIT OF DETECTION; LIMIT OF QUANTITATION; NONHUMAN; PLASMABLAST; PRIORITY JOURNAL; RHESUS MONKEY; VIRUS ISOLATION; ZIKA FEVER; ZIKA VIRUS; ANIMAL; DRUG EFFECT; HUMAN; HUMORAL IMMUNITY; IMMUNOLOGY; MACACA; VIROLOGY; VIRUS LOAD;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEUTRALIZING; HUMANS; IMMUNITY, HUMORAL; MACACA; VIRAL LOAD; ZIKA VIRUS INFECTION;

EID: 85030571167     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.aan8184     Document Type: Article

References (35)

1. M. R. Reynolds, A. M. Jones, E. E. Petersen, E. H. Lee, M. E. Rice, A. Bingham, S. R. Ellington, N. Evert, S. Reagan-Steiner, T. Oduyebo, C. M. Brown, S. Martin, N. Ahmad, J. Bhatnagar, J. Macdonald, C. Gould, A. D. Fine, K. D. Polen, H. Lake-Burger, C. L. Hillard, N. Hall, M. M. Yazdy, K. Slaughter, J. N. Sommer, A. Adamski, M. Raycraft, S. Fleck-Derderian, J. Gupta, K. Newsome, M. Baez-Santiago, S. Slavinski, J. L. White, C. A. Moore, C. K. Shapiro-Mendoza, L. Petersen, C. Boyle, D. J. Jamieson, D. Meaney-Delman, M. A. Honein; U.S. Zika Pregnancy Registry Collaboration, Vital signs: Update on Zika virus-associated birth defects and evaluation of all U.S. infants with congenital Zika virus exposure-U.S. Zika Pregnancy Registry, 2016. MMWR Morb. Mortal. Wkly Rep. 66, 366-373 (2017)
2. P. Brasil, J. P. Pereira Jr., M. E. Moreira, R. M. Ribeiro Nogueira, L. Damasceno, M. Wakimoto, R. S. Rabello, S. G. Valderramos, U.-A. Halai, T. S. Salles, A. A. Zin, D. Horovitz, P. Daltro, M. Boechat, C. Raja Gabaglia, P. Carvalho Sequeira, J. H. Pilotto, R. Medialdea-Carrera, D. Cotrim Cunha, L. M. Carvalho, M. Pone, A. Machado Siqueira, G. A. Calvet, A. E. Rodrigues , E. S. Neves, P. R. Nassar Carvalho, R. H. Hasue, P. B. Marschik, C. Einspieler, C. Janzen, J. D. Cherry, A. M. Bispo Filippis, K. Nielsen-Saines, Zika virus infection in pregnant women in Rio de Janeiro. N. Engl. J. Med. 375, 2321-2334 (2016)
3. J. Mlakar, M. Korva, N. Tul, M. Popovi?, M. PoljŜak-Prijatelj, J. Mraz, M. Kolenc, K. Resman Rus, T. Vesnaver Vipotnik, V. Fabjan VoduŜek, A. Vizjak, J. Piẑem, M. Petrovec, T. AvŜi? Z;upanc, Zika virus associated with microcephaly. N. Engl. J. Med. 374, 951-958 (2016)
4. World Health Organization, Fifth Meeting of the Emergency Committee Under the International Health Regulations (2005) Regarding Microcephaly, Other Neurological Disorders and Zika Virus (World Health Organization, 2016); www.who.int/mediacentre/ news/statements/2016/zika-fifth-ec/en/ [accessed 24 August 2017]
5. The IMpact-RSV Study Group, Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics 102, 531-537 (1998)
6. J. Jückstock, M. Rothenburger, K. Friese, F. Traunmüller, Passive immunization against congenital cytomegalovirus infection: Current state of knowledge. Pharmacology 95, 209-217 (2015)
7. N. E. Simister, Placental transport of immunoglobulin G. Vaccine 21, 3365-3369 (2003)
8. G. Barba-Spaeth, W. Dejnirattisai, A. Rouvinski, M.-C. Vaney, I. Medits, A. Sharma, E. Simon-Lorière, A. Sakuntabhai, V.M. Cao-Lormeau, A. Haouz, P. England, K. Stiasny, J. Mongkolsapaya, F. X. Heinz, G. R. Screaton, F. A. Rey, Structural basis of potent Zika-dengue virus antibody cross-neutralization. Nature 536, 48-53 (2016)
9. C.-J. Lai, A. P. Goncalvez, R. Men, C. Wernly, O. Donau, R. E. Engle, R. H. Purcell, Epitope determinants of a chimpanzee dengue virus type 4 (DENV-4)-neutralizing antibody and protection against DENV-4 challenge in mice and rhesus monkeys by passively transferred humanized antibody. J. Virol. 81, 12766-12774 (2007)
10. D. M. Magnani, M. J. Ricciardi, V. K. Bailey, M. J. Gutman, N. Pedreño-Lopez, C. G. T. Silveira, H. S. Maxwell, A. Domingues, L. Gonzalez-Nieto, Q. Su, R. M. Newman, M. Pack, M. A. Martins, J. M. Martinez-Navio, S. P. Fuchs, E. G. Rakasz, T. M. Allen, S. S. Whitehead, D. R. Burton, G. Gao, R. C. Desrosiers, E. G. Kallas, D. I. Watkins, Dengue virus evades AAV-mediated neutralizing antibody prophylaxis in rhesus monkeys. Mol. Ther. (2017)
11. S. Sukupolvi-Petty, S. K. Austin, M. Engle, J. D. Brien, K. A. Dowd, K. L. Williams, S. Johnson, R. Rico-Hesse, E. Harris, T. C. Pierson, D. H. Fremont, M. S. Diamond, Structure and function analysis of therapeutic monoclonal antibodies against dengue virus type 2. J. Virol. 84, 9227-9239 (2010)
12. A. J. Hessell, L. Hangartner, M. Hunter, C. E. G. Havenith, F. J. Beurskens, J. M. Bakker, C. M. S. Lanigan, G. Landucci, D. N. Forthal, P. W. H. I. Parren, P. A. Marx, D. R. Burton, Fc receptor but not complement binding is important in antibody protection against HIV. Nature 449, 101-104 (2007)
13. M. C. Bonaldo, I. P. Ribeiro, N. S. Lima, A. A. C. Santos, L. S. R. Menezes, S. O. D. Cruz, I. S. Mello, N. D. Furtado, E. E. Moura, L. Damasceno, K. A. B. Silva, M. G. Castro, A. L. Gerber, L. G. P. Almeida, R. Lourenço-Oliveira, A. T. R. Vasconcelos, P. Brasil, Isolation of infective Zika virus from urine and saliva of patients in Brazil. PLOS Negl. Trop. Dis. 10, e0004816 (2016)
14. L. M. Styer, K. A. Kent, R. G. Albright, C. J. Bennett, L. D. Kramer, K. A. Bernard, Mosquitoes inoculate high doses of West Nile virus as they probe and feed on live hosts. PLOS Pathog. 3, 1262-1270 (2007)
15. R. A. Larocca, P. Abbink, J. P. S. Peron, P. M. A. Zanotto, M. J. Iampietro, A. Badamchi-Zadeh, M. Boyd, D. Ng'ang'a, M. Kirilova, R. Nityanandam, N. B. Mercado, Z. Li, E. T. Moseley, C. A. Bricault, E. N. Borducchi, P. B. Giglio, D. Jetton, G. Neubauer, J. P. Nkolola, L. F. Maxfield, R. A. Barrera, R. G. Jarman, K. H. Eckels, N. L. Michael, S. J. Thomas, D. H. Barouch, Vaccine protection against Zika virus from Brazil. Nature 536, 474-478 (2016)
16. K. A. Dowd, S.-Y. Ko, K. M. Morabito, E. S. Yang, R. S. Pelc, C. R. DeMaso, L. R. Castilho, P. Abbink, M. Boyd, R. Nityanandam, D. N. Gordon, J. R. Gallagher, X. Chen, J.-P. Todd, Y. Tsybovsky, A. Harris, Y.-J. S. Huang, S. Higgs, D. L. Vanlandingham, H. Andersen, M. G. Lewis, R. Barrera, K. H. Eckels, R. G. Jarman, M. C. Nason, D. H. Barouch, M. Roederer, W.-P. Kong, J. R. Mascola, T. C. Pierson, B. S. Graham, Rapid development of a DNA vaccine for Zika virus. Science 354, 237-240 (2016)
17. H. D. Marston, N. Lurie, L. L. Borio, A. S. Fauci, Considerations for developing a Zika virus vaccine. N. Engl. J. Med. 375, 1209-1212 (2016)
18. T. T. Wang, J. Sewatanon, M. J. Memoli, J. Wrammert, S. Bournazos, S. K. Bhaumik, B. A. Pinsky, K. Chokephaibulkit, N. Onlamoon, K. Pattanapanyasat, J. K. Taubenberger, R. Ahmed, J. V. Ravetch, IgG antibodies to dengue enhanced for FcgRIIIA binding determine disease severity. Science 355, 395-398 (2017)
19. S. B. Halstead, In vivo enhancement of dengue virus infection in rhesus monkeys by passively transferred antibody. J. Infect. Dis. 140, 527-533 (1979)
20. K. A. Dowd, T. C. Pierson, Antibody-mediated neutralization of flaviviruses: A reductionist view. Virology 411, 306-315 (2011)
21. M. G. Guzman, M. Alvarez, S. B. Halstead, Secondary infection as a risk factor for dengue hemorrhagic fever/dengue shock syndrome: An historical perspective and role of antibody-dependent enhancement of infection. Arch. Virol. 158, 1445-1459 (2013)
22. S. V. Bardina, P. Bunduc, S. Tripathi, J. Duehr, J. J. Frere, J. A. Brown, R. Nachbagauer, G. A. Foster, D. Krysztof, D. Tortorella, S. L. Stramer, A. García-Sastre, F. Krammer, J. K. Lim, Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity. Science 356, 175-180 (2017)
23. W. Dejnirattisai, P. Supasa, W. Wongwiwat, A. Rouvinski, G. Barba-Spaeth, T. Duangchinda, A.Sakuntabhai, V.M. Cao-Lormeau, P. Malasit, F. A. Rey, J. Mongkolsapaya, G. R. Screaton, Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with Zika virus. Nat. Immunol. 17, 1102-1108 (2016)
24. L. Priyamvada, K. M. Quicke, W. H. Hudson, N. Onlamoon, J. Sewatanon, S. Edupuganti, K. Pattanapanyasat, K. Chokephaibulkit, M. J. Mulligan, P. C. Wilson, R. Ahmed, M. S. Suthar, J. Wrammert, Human antibody responses after dengue virus infection are highly cross-reactive to Zika virus. Proc. Natl. Acad. Sci. U.S.A. 113, 7852-7857 (2016)
25. G. J. Robbie, R. Criste, W. F.Dall'acqua, K. Jensen, N. K. Patel, G. A. Losonsky, M. P. Griffin, A novel investigational Fc-modified humanized monoclonal antibody, motavizumab-YTE, has an extended half-life in healthy adults. Antimicrob. Agents Chemother. 57, 6147-6153 (2013)
26. G. Sapparapu, E. Fernandez, N. Kose, B. Cao, J. M. Fox, R. G. Bombardi, H. Zhao, C. A. Nelson, A. L. Bryan, T. Barnes, E. Davidson, I. U. Mysorekar, D. H. Fremont, B. J. Doranz, M. S. Diamond, J. E. Crowe, Neutralizing human antibodies prevent Zika virus replication and fetal disease in mice. Nature 540, 443-447 (2016)
27. A. P. Durbin, R. A. Karron, W. Sun, D.W. Vaughn,M. J. Reynolds, J. R. Perreault, B. Thumar, R.Men, C.-J. Lai, W. R. Elkins, R. M. Chanock, B. R. Murphy, S. S. Whitehead, Attenuation and immunogenicity in humans of a live dengue virus type-4 vaccine candidate with a 30 nucleotide deletion in its 3'-untranslated region. Am. J. Trop. Med. Hyg. 65, 405-413 (2001)
28. I. J. Fuss, M. E. Kanof, P. D. Smith, H. Zola, Isolation of whole mononuclear cells from peripheral blood and cord blood. Curr. Protoc. Immunol. Chapter 7, Unit7.1 (2009)
29. J. D. Brien, H. M. Lazear, M. S. Diamond, Propagation, quantification, detection, and storage of West Nile virus. Curr. Protoc. Microbiol. 31, 15D31-15D318 (2013)
30. R. Alwis, A. M. Silva, Measuring antibody neutralization of dengue virus (DENV) using a flow cytometry-based technique. Methods Mol. Biol. 1138, 27-39 (2014)
31. A. A. Kraus, W. Messer, L. B. Haymore, A. M. Silva, Comparison of plaque-and flow cytometry-based methods for measuring dengue virus neutralization. J. Clin. Microbiol. 45, 3777-3780 (2007)
32. G. A. Santiago, E. Vergne, Y. Quiles, J. Cosme, J. Vazquez, J. F. Medina, F. Medina, C. Colón, H.Margolis, J. L.Muñoz-Jordán, Analytical and clinicalperformance of the CDC real timeRT-PCR assay for detection and typing of dengue virus. PLOS Negl. Trop. Dis. 7, e2311 (2013)
33. B. W. Johnson, B. J. Russell, R. S. Lanciotti, Serotype-specific detection of dengue viruses in a fourplex real-time reverse transcriptase PCR assay. J. Clin. Microbiol. 43, 4977-4983 (2005)
34. H. Zhao, E. Fernandez, K. A. Dowd, S. D. Speer, D. J. Platt, M. J. Gorman, J. Govero, C. A. Nelson, T. C. Pierson, M. S. Diamond, D. H. Fremont, Structural basis of Zika virusspecific antibody protection. Cell 166, 1016-1027 (2016)
35. T. F.Rogers, E. C.Goodwin, B.Briney, D. Sok,N.Beutler, A. Strubel, R.Nedellec,K. Le, M.E. Brown, D. R. Burton, L. M. Walker, Zika virus activates de novo and cross-reactive memory B cell responses in dengue-experienced donors. Sci. Immunol. 2, eaan6809 (2017)